Revista Portuguesa de Pneumologia


ISSN: 2173-5115

Impact Factor 2016: 1.560

Allergic bronchopulmonary aspergillosis treated successfully with omalizumab




10.1016/j.rppnen.2017.05.006

Download PDF

The reliability of short-term measurement of heart rate variability during spontaneous breathing in people with chronic obstructive pulmonary disease




10.1016/j.rppnen.2017.06.001

Download PDF

Atypical pyoderma gangrenosum simulating pectoral abscess managed using negative pressure wound therapy




10.1016/j.rppnen.2017.05.007

Download PDF

Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence




10.1016/j.rppnen.2017.05.005

Download PDF

Analysis of sarcoidosis in the Oporto region (Portugal)




10.1016/j.rppnen.2017.05.004

Download PDF

Effects of exposure to biomass burning on pulmonary inflammatory markers and pulmonary function in individuals with COPD




10.1016/j.rppnen.2017.04.003

Download PDF

Does any association Exist between Chronic Obstructive pulmonary Disease and Erectile Dysfunction? The DECODED study




10.1016/j.rppnen.2017.04.005

Download PDF

The role of physiotherapy in patients undergoing pulmonary surgery for lung cancer. A literature review




10.1016/j.rppnen.2017.05.003

Download PDF

Does omalizumab impair glucose homeostasis in a patient with severe persistent asthma and type 2 diabetes mellitus?




10.1016/j.rppnen.2017.05.002

Download PDF

Assessment of dyspnea and dynamic hyperinflation in male patients with chronic obstructive pulmonary disease during a six minute walk test and an incremental treadmill cardiorespiratory exercise test




10.1016/j.rppnen.2017.04.007

Download PDF

Metrics

  • Impact Factor: 1.560(2016)
  • 5-years Impact Factor: 1,100
  • SCImago Journal Rank (SJR):0,29
  • Source Normalized Impact per Paper (SNIP):0,685